Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with V

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
9286 Q3 2021 VANILLIN ORAL TABLET 1.50 mg MDE Replacement
9286 Q4 2021 VANILLIN ORAL TABLET 4.5 mg MDE Replacement
9292 Q3 2021 VANILLIN ORAL TABLET, FILM COATED 0.94 mg MDE Replacement
9292 Q4 2021 VANILLIN ORAL TABLET, FILM COATED 5 mg MDE Replacement
9293 Q3 2021 VANILLIN ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.80 mg MDE Replacement
9293 Q4 2021 VANILLIN ORAL TABLET, FILM COATED, EXTENDED RELEASE 0.8 mg MDE Replacement
9309 Q3 2021 VEGETABLE OIL, HYDROGENATED ORAL TABLET 40.00 mg MDE Replacement
9309 Q4 2021 VEGETABLE OIL, HYDROGENATED ORAL TABLET 42 mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English